UPDATE : Thursday, October 18, 2018
상단여백
Xofigo combinations raise fracture risk
Combinations using Bayer Korea’s prostate cancer treatment Xofigo Inj. (ing...
by Lee Hye-seon  |  2018-07-19 13:59
라인
Joint R&D program to test Keytruda combo in breast cancer patients
The Korea Drug Development Fund (KDDF) and MSD Korea have selected Genexine...
by Marian Chu  |  2018-07-18 17:53
라인
Kolon Life Science inks deal to sell Invossa to China
Kolon Life Science said Wednesday it has signed a deal to sell 230 billion ...
by So Jae-hyeon  |  2018-07-18 16:46
라인
L&K Biomed gets FDA nod for sacroiliac joint disease implant system
L&K Biomed has received the U.S. Food and Drug Administration’s approval We...
by Marian Chu  |  2018-07-18 16:26
라인
SK Bioscience to expand vaccine production facility
SK Bioscience is pursuing its growth strategy by expanding its vaccine prod...
by Marian Chu  |  2018-07-18 16:13
라인
ViroMed secures DNA production plant in US
ViroMed said Wednesday it acquired a DNA production facility in San Diego, ...
by Marian Chu  |  2018-07-18 15:02
라인
Dong-A ST’s Jublia dominates athlete’s foot drugs
The sales of Dong-A ST’s Jublia, a toenail fungal treatment, has grown rapi...
by So Jae-hyeon  |  2018-07-18 11:50
라인
Novo Nordisk Korea gets nod for diabetes drug Fiasp
Novo Nordisk Korea got the Ministry of Food and Drug Safety’s approval for ...
by Marian Chu  |  2018-07-18 11:50
라인
‘Koreans increasingly seeking out hair loss treatment’
The number of Koreans in their 40s getting hair loss treatments is increasi...
by Marian Chu  |  2018-07-17 16:08
라인
YD Life Science to proceed with P2 trial for diabetic retinopathy treatment
YD Life Science said it got the U.S. Food and Drug Administration’s go-ahea...
by Lee Han-soo  |  2018-07-17 14:52
라인
30% of psoriasis patients take more than 5 years to find correct therapy
Psoriasis patients see an average of three doctors and try four types of tr...
by Marian Chu  |  2018-07-17 14:52
라인
Pharmbio launched CINV treatment
Pharmbio Korea said Tuesday that it has released a prefilled syringe versio...
by Lee Han-soo  |  2018-07-17 14:02
라인
Korean eye drops selling well overseas
Korean eye drops made by Huons, Sam Chun Dang Pharm, and Hanlim Pharm are i...
by So Jae-hyeon  |  2018-07-17 11:36
라인
Multinational pharma focus on P3 trials; locals have more P1 trials
Multinational pharmaceutical firms had more phase 3 trials underway in Kore...
by Marian Chu  |  2018-07-17 11:27
라인
Access Bio signs $1.12-mil. contract for malaria diagnostic test
Access Bio is expanding its reach into Africa with its malaria rapid diagno...
by Marian Chu  |  2018-07-16 16:23
라인
FDA nods Qurient’s multidrug-resistant TB treatment for P2 clinical trials
Qurient said Monday that the U.S. Food and Drug Administration (FDA) has ap...
by Lee Han-soo  |  2018-07-16 15:10
라인
Korean take more drugs than OECD average
Koreans take more medications than most other members of the Organization f...
by Lee Han-soo  |  2018-07-16 12:37
라인
Japanese drugmakers in Korea showed robust performances last year
Japanese multinational pharmaceutical companies have continued to show robu...
by Lee Han-soo  |  2018-07-13 16:32
라인
Samsung BioLogics violated accounting standards: SFC
The Securities and Futures Commission (SFC) said Thursday it has concluded ...
by Lee Han-soo  |  2018-07-12 18:36
라인
Edarbi, Saxenda prescribed in major hospitals
A new hypertension drug Edarbi by Takeda Pharmaceuticals Korea and Dong-A S...
by So Jae-hyeon  |  2018-07-11 15:42
여백
여백
여백
Back to Top